Redmond Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,074
Closed -$1.27M 159
2024
Q2
$1.27M Sell
3,074
-44
-1% -$17.4K 0.42% 85
2024
Q1
$1.26M Sell
3,118
-32
-1% -$11.3K 0.4% 88
2023
Q4
$966K Sell
3,150
-297
-9% -$80.2K 0.31% 102
2023
Q3
$835K Hold
3,447
0.3% 106
2023
Q2
$828K Hold
3,447
0.27% 108
2023
Q1
$648K Hold
3,447
0.22% 118
2022
Q4
$732K Hold
3,447
0.26% 117
2022
Q3
$542K Sell
3,447
-21
-0.6% -$3.35K 0.2% 127
2022
Q2
$519K Hold
3,468
0.19% 135
2022
Q1
$567K Buy
3,468
+38
+1% +$6.26K 0.17% 143
2021
Q4
$747K Buy
3,430
+27
+0.8% +$5.65K 0.21% 140
2021
Q3
$644K Hold
3,403
0.2% 134
2021
Q2
$601K Hold
3,403
0.18% 150
2021
Q1
$558K Hold
3,403
0.17% 149
2020
Q4
$474K Hold
3,403
0.17% 144
2020
Q3
$380K Buy
3,403
+15
+0.4% +$1.73K 0.16% 138
2020
Q2
$315K Hold
3,388
0.13% 141
2020
Q1
$249K Buy
+3,388
New +$294K 0.12% 152

Other funds holding MEDP

Redmond Asset Management's MEDP Position: Q3 2024 in Review

Redmond Asset Management sold out of Medpace (MEDP) in Q3 2024, closing a stake of 3,074 shares — an estimated $1.27M sold.

Redmond Asset Management first reported a position in MEDP in Q1 2020 and held it in 18 quarters. The position peaked at $1.27M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Redmond Asset Management reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Redmond Asset Management sold 3,074 Medpace shares in Q3 2024, an estimated $1.27M.
  • Redmond Asset Management first reported a position in Medpace in Q1 2020 and held it in 18 quarters.
  • Redmond Asset Management's Medpace position peaked at $1.27M in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Redmond Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.